CARE Launches Global Partnership With iDE and IDinsight To Expand Sanitation in Rural Areas
The new partnership aims to increase access to safe and durable household toilets by harnessing private sector solutions, government investments, community-led financial mechanisms, and rigorous evidence to measure success. While effective sanitation technologies already exist, systemic barriers—including weak sanitation supply chains, limited household access to finance, and low public investment—have stalled progress towards universal household sanitation, particularly in rural Sub-Saharan Africa.
The partnership will launch this month with a 1-year pilot program in Zambia , connecting sanitation entrepreneurs and public officials with Village Savings and Loans Associations (VSLAs) —CARE global flagship initiative that enables women to save and borrow money in the absence of a formal bank —to reinforce demand for sanitation, increase access to finance, and foster a new generation of sanitation entrepreneurs.
While government commitment and community awareness are key to bridging the sanitation gap, sanitation entrepreneurs and businesses are critical in ensuring that rural households have affordable sanitation options they will use and maintain. By increasing household sanitation access, CARE and partners seek to promote individual dignity and improve public health as diarrheal diseases remain a leading cause of mortality, morbidity, and malnutrition in many parts of the world.
This new partnership leverages the organizations' collective resources and brings together each organization's distinct strengths:
CARE sees this partnership as a powerful opportunity to leverage its VSLA network and accelerate progress towards global sanitation. 'By combining iDE's market-driven sanitation expertise with CARE's deep community relationships and financial inclusion platforms, we can unlock faster, more sustainable access to improved sanitation products and services,' said Rod Beadle, Director of CARE's Water Team.
For Elise Mann, Global WaSH Director at iDE, the partnership is an opportunity for rural sanitation entrepreneurs to build their customer base, starting with early adopters who influence the wider community. 'We know that VSLA members can play this early adopter role and accelerate investments in other households. Success means that more households will have safe toilets more quickly – improving their own health and security, and the health of their wider communities.'
IDinsight, a global leader in empowering decision-makers with data and evidence, will rigorously assess the model's outcomes on improving people's lives. 'The partnership between CARE and iDE on market-based sanitation can leverage organizational complementarities as well as existing assets, footprints, and relationships to drive innovation, cost-effectiveness, and scalability,' said Rico Bergemann, Associate Director at IDinsight.
In Zambia, the partnership is working in collaboration with the Ministry of Water Development and Sanitation, District and Ward governments, and other public sector institutions. There is urgency to this issue. 'Currently, only half of Zambian households have safe sanitation, but the Government of Zambia has set a 90 percent household sanitation coverage target by 2030. There is a lot to do to increase sanitation uptake.' said Moses Mumba, Program Manager at CARE Zambia. 'This pilot will help inform national and local government approaches to scaling sanitation and help achieve those ambitious targets.'
This partnership is designed to test a model that can be reproduced anywhere market conditions and community-led platforms are amenable. While the partnership aims to create accelerated pathways to close the sanitation gap in Zambia, in so doing, it will unlock complementary benefits across health, nutrition, education, and the economy—advancing opportunities and dignity for millions. 'At a time when funding for foreign aid is increasingly scarce, solutions that are cost-effective, lifesaving and scalable are more important than ever,' said Anita Akella, CARE's Director of Impact at Scale.
For media inquiries, please email [email protected]
Note to editors:
About CARE: Founded in 1945 with the creation of the CARE Package®, CARE is a leading humanitarian organization fighting global poverty. CARE places special focus on working alongside women and girls. Equipped with the proper resources, women and girls have the power to lift whole families and entire communities out of poverty. In 2024, CARE worked in 121 countries, reaching 53 million people through 1,450 projects. To learn more, visit www.care.org
About iDE: iDE's mission is to end global poverty. The organization believes that catalyzing the power of local markets is the best way to do this. iDE works with local entrepreneurs who connect underserved, last-mile markets with products and services that enable people to move up the economic ladder. iDE works in the sectors of agriculture, WaSH, and nutrition across 12 countries and has impacted more than 44 million people to date. To learn more, visit www.ide.org
About IDinsight: IDinsight is a global non-profit research, data analytics, and advisory organization that helps development leaders maximize their social impact. To learn more, visit: www.idinsight.org
Visit 3BL Media to see more multimedia and stories from Care USA
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
IUP's proposed medical school earns key 'candidate status' from accreditors
INDIANA, Pa. – Indiana University of Pennsylvania's proposed college of osteopathic medicine has achieved a 'critical milestone' in being elevated to candidate status by the American Osteopathic Association's Commission on Osteopathic College Accreditation. This is the second step in the accreditation process. Pre-accreditation status is the next step that can be applied for in the next two years, and that allows IUP to begin recruiting students to the future medical school. 'It's been incredibly hard work to get to this important stage, but also incredibly rewarding,' the proposed college's founding dean, Dr. Miko Rose, said in a statement. 'The IUP and Indiana-area community, our legislators, our alumni and friends, local businesses and schools, and our regional and state health care partners and leaders have been unwavering in their support, encouragement and confidence in IUP.' Rose added that she couldn't be more proud of the work already completed and she's excited for the future. 'This designation is a critical milestone in our work to establish a college of osteopathic medicine at IUP,' university President Michael Driscoll said in a release. He said the faculty and staff of the university have worked at 'light speed' since the IUP Council of Trustees endorsed pursuit of the proposed medical college in December 2022. 'This achievement reflects thousands of hours of hard work, preparation and support from so many people, including our legislators, (state) Sen. Joe Pittman, (state) Rep. Jim Struzzi and (U.S.) Congressman Guy Reschenthaler,' Driscoll said. 'I thank them, our donors, the proposed college of osteopathic medicine team and its advisory groups, and everyone at IUP and in our community who has been part of advancing this project.' Once up and running, the proposed college of medicine will be housed in a new health sciences center at the Indiana campus. The university's long-range facilities master plan recommends use of Johnson Hall, Uhler Hall and Stright Hall as the site of that grouping. All three buildings are scheduled for renovations. Once accredited, the proposed college of osteopathic medicine is set to receive its first class of students in the fall of 2027. Solve the daily Crossword
Medscape
an hour ago
- Medscape
Smartwatches Won't Fix the Burnout Crisis in Medicine
This transcript has been edited for clarity. Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine. Burnout is a huge problem across multiple professions in the United States. Grades K-12 teachers have about a 50% burnout rate. So do people in quality assurance. But I was unable to find a profession with a higher rate of burnout, or a higher potential for harm from burnout, than — you guessed it — physicians. A 2022 survey found that 63% of physicians had burnout, rates that have been among the highest of all US workers since 2011. And this is a huge problem. When docs are burned out, they are more likely to commit medical errors, be named in malpractice suits, and even exhibit racial biases. Administrators of health systems have taken notice. But their solutions have often been criticized as tone-deaf. 'Mandatory burnout workshops' are not helping anyone's burnout, I promise you. So I was a bit concerned by a study that came out this week that offered a relatively simple solution to what is a really complex problem. Can you actually cut burnout in half by giving physicians a smartwatch? Before we dig into the study, let's talk about burnout a little bit. I think there's sort of a Potter Stewart definition of burnout: 'I know it when I see it.' But the real description comes from Christina Maslach, who characterized it as a psychological syndrome brought about by chronic occupational stress characterized by emotional exhaustion, depersonalization or cynicism, and a reduced sense of personal accomplishment. Sound familiar? I know. It's not uncommon. And it goes without saying that depersonalization and cynicism are just terrible traits to have in a doctor. It's not just workload that leads to burnout, according to most psychologists; it's this combination of workload and a feeling that you don't have autonomy. That you are not the master of your fate or the captain of your soul. Big issues. So how is a smartwatch supposed to help? Well, the idea isn't crazy. Smartwatches are miniature biofeedback devices. They tell you about your heart rate, your step count, how much you slept. Those little data points can lead to some real behavior change. This is anecdotal, but multiple people have told me they've cut back on drinking alcohol because they noticed that their smartwatch-reported sleep quality is worse on nights that they drink. Researchers at the Mayo Clinic and University of Colorado thought that maybe giving smartwatches to physicians would lead them to make small lifestyle changes, like getting more sleep, that would reduce this problem of burnout. Here's how the trial worked, as reported in JAMA Network Open . One hundred and eighty-four physicians — about half attendings, half residents and fellows, and about 60% female — were randomized to two groups. One group got a smartwatch, specifically the Venu 2 Plus from Garmin, to wear for 6 months. The other group got nothing. Well, to be fair, they got a smartwatch as well — just after a 6-month wait so the team would have 6 months of high-quality comparison data. At the beginning of the study and several times over those 6 months, the participants took surveys about their mental health: a resilience survey, a quality-of-life survey, a depression survey, a stress survey, a sleep survey and, importantly, a burnout survey. At baseline, 50% of people in the intervention arm were burned out and 43% were burned out in the control arm. After 6 months, burnout dropped to 41% in the intervention arm and rose to 51% in the control arm. The difference here was not technically statistically significant, but after accounting for the fact that burnout was higher at baseline in the intervention group, the team concluded that the odds of burnout were about 50% lower after 6 months of the smartwatch intervention. I know statistics can get confusing in situations like this. I think sometimes it helps just to look at the graph and make your own judgment: Burnout down a bit with a smartwatch, up a bit without a smartwatch. Fine. There was also about a 20% improvement in resilience scores, while there were no differences in quality of life, depression, or stress scores. So… is that it? Have we solved this problem plaguing all of healthcare and multiple other industries across the United States? Smartwatches? My fear is that some C-suite execs will look at this study and think they can cut burnout rates in half by sending a bunch of smartwatches around. Maybe it seems obvious to you that it wouldn't actually work, but let's break down a bit how the results of this study may be somewhat skewed. The most important thing to note is that this study was not blinded. The people in the smartwatch group knew they were in the smartwatch group because… they were wearing the smartwatch. It's hard to imagine a way to blind this study, to be fair, although I suppose you could give everyone a smartwatch but half the people get fake data or something. But once you know that you are in the intervention group, biases in your answers creep in. Just imagine you're in the study. At baseline, you take these surveys, then they give you a smartwatch, and 6 months later you take a bunch of surveys again. Maybe you skew your answers a bit, even unconsciously, because you like the people running the study or science in general, or maybe even smartwatches. The authors acknowledge this but minimize it, suggesting that if this 'social desirability bias' was present, it should improve scores across all the surveys. I mean, okay, but to be honest, the score differences are pretty marginal across the board, so I don't find that argument very compelling. The real issue here is that this study puts the locus of control in the wrong place, as many burnout interventions do. It puts the responsibility for burnout on the shoulders of the burned-out physicians. It suggests we can tolerate our jobs better if we just change our outlook: Sleep more, meditate more, live in the moment, do tai chi, etc. But I would argue that the problem with burnout is not in the mind of the physician; the problem is the system in which we work. More than 75% of physicians in the United States today are employed by hospitals, health systems, or other corporate entities. The private-practice model is rapidly dying and the physician workforce is learning what it means to be labor instead of management. They are feeling what it is like to be exploited, for lack of a better word — pushed to see more patients in less time, pushed to generate more RVUs, pushed to work weekends and nights to increase margins. It's not what they signed up for. The problem of burnout is from the system. If you want to cut rates in half, you don't send docs a smartwatch. You give them more time to see fewer patients. You change the insurance system that leaves us on the phone arguing for prior authorization for hours at a time. And if that affects the bottom line of the health system, you look for cuts in the — and this is true — 10 administrators for each physician in the US. Look, I love my smartwatch. It helps me delete emails while I'm waiting for the elevator. But the solution to physician burnout is not here. It's out there.
Yahoo
2 hours ago
- Yahoo
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
Transforms present balance sheet with significant reduction in liabilities Largest shareholder is long-term strategic investor NEW YORK, August 19, 2025--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has significantly improved its financial position over the past 5 months through a material reduction in liabilities, while maintaining total assets of over $17 million as of June 30, 2025. "The recent significant improvement in our financial position gives TNF a stronger platform for growth opportunities and taking advantage of shareholder value creation opportunities," said TNF President and Chief Medical Officer, Mitchell Glass, M.D. "We are pleased to have the continued support of our largest investors, and look forward to updating investors on TNF's business developments in the near future, including our ongoing collaboration with Renova on GLP-induced inflammation and muscle damage." The improvements in the Company's financial position will be reflected in future financial statements of the Company. About TNF Pharmaceuticals, Inc. TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. The Company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the rapidly growing CBD market, which includes both FDA approved drugs and CBD products not currently regulated as drugs. For more information, visit Cautionary Statement Regarding Forward-Looking Statements This press release may contain forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any expected future results, performance, or achievements. Forward-looking statements speak only as of the date they are made and neither the Company nor its affiliates assume any duty to update forward-looking statements. Words such as "anticipate," "believe," "could," "estimate," "expect," "may," "plan," "will," "would'' and other similar expressions are intended to identify these forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: unanticipated financial setbacks, the Company needing to pursue financing options that could adversely impact our liabilities due to adverse market conditions, the Company's ability to maintain compliance with the Nasdaq Stock Market's listing standards; the timing of, and the Company's ability to, obtain and maintain regulatory approvals for clinical trials of the Company's pharmaceutical candidates; the timing and results of the Company's planned clinical trials for its pharmaceutical candidates; the amount of funds the Company requires for its pharmaceutical candidates; increased levels of competition; changes in political, economic or regulatory conditions generally and in the markets in which the Company operates; the Company's ability to retain and attract senior management and other key employees; the Company's ability to quickly and effectively respond to new technological developments; and the Company's ability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the Company's proprietary rights. A discussion of these and other factors with respect to the Company is set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed by the Company on April 11, 2025, and subsequent reports that the Company files with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts Investor Contact: Sign in to access your portfolio
